Evidence map›Paper›PMID 31792253›Full record

ArticleScientific reports2019

Dual Action of Sulfated Hyaluronan on Angiogenic Processes in Relation to Vascular Endothelial Growth Factor-A.

Linda Koehler, Gloria Ruiz-Gómez, Kanagasabai Balamurugan, Sandra Rother, Joanna Freyse, Stephanie Möller, Matthias Schnabelrauch, Sebastian Köhling, Snezana Djordjevic, Dieter Scharnweber and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. New anti-angiogenic compound based on chemically modified heparin.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2022
    Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Linda KoehlerInstitute of Materials Science, Max Bergmann Center of Biomaterials, TU Dresden, Budapester Straße 27, 01069, Dresden, Germany.
Gloria Ruiz-GómezStructural Bioinformatics, BIOTEC TU Dresden, Tatzberg 47-51, 01307, Dresden, Germany.
Kanagasabai BalamuruganStructural Bioinformatics, BIOTEC TU Dresden, Tatzberg 47-51, 01307, Dresden, Germany.
Sandra RotherInstitute of Materials Science, Max Bergmann Center of Biomaterials, TU Dresden, Budapester Straße 27, 01069, Dresden, Germany.
Joanna FreyseInstitute of Pharmacy, Freie Universität Berlin, Königin-Luise-Straße 2+4, 14195, Berlin, Germany.
Stephanie MöllerBiomaterials Department, INNOVENT e.V., Prüssingstraße 27 B, 07745, Jena, Germany.
Matthias SchnabelrauchBiomaterials Department, INNOVENT e.V., Prüssingstraße 27 B, 07745, Jena, Germany.
Sebastian KöhlingInstitute of Pharmacy, Freie Universität Berlin, Königin-Luise-Straße 2+4, 14195, Berlin, Germany.
Snezana DjordjevicInstitute of Structural and Molecular Biology, University College London, Gower Street, Darwin Building, WC1E 6BT, London, United Kingdom.
Dieter ScharnweberInstitute of Materials Science, Max Bergmann Center of Biomaterials, TU Dresden, Budapester Straße 27, 01069, Dresden, Germany.
Jörg RademannInstitute of Pharmacy, Freie Universität Berlin, Königin-Luise-Straße 2+4, 14195, Berlin, Germany.
M Teresa PisabarroStructural Bioinformatics, BIOTEC TU Dresden, Tatzberg 47-51, 01307, Dresden, Germany. Maria_Teresa.Pisabarro@tu-dresden.de.
Vera HintzeInstitute of Materials Science, Max Bergmann Center of Biomaterials, TU Dresden, Budapester Straße 27, 01069, Dresden, Germany. Vera.Hintze@tu-dresden.de.
Technische Universität Dresden · DEFreie Universität Berlin · DEMax Bergmann Zentrum für Biomaterialien · DEInnovent · DEInstitute of Structural and Molecular Biology · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pathological healing characterized by abnormal angiogenesis presents a serious burden to patients' quality of life requiring innovative treatment strategies. Glycosaminoglycans (GAG) are important regulators of angiogenic processes. This experimental and computational study revealed how sulfated GAG derivatives (sGAG) influence the interplay of vascular endothelial growth factor (VEGF)

Indexed as

Binding SitesChondroitin SulfatesComputer SimulationGlycosaminoglycansHumansHuman Umbilical Vein Endothelial CellsHyaluronic AcidImmobilized ProteinsModels, MolecularMolecular Docking SimulationMolecular Dynamics SimulationNeovascularization, PhysiologicPhosphorylationProtein DomainsSpheroids, CellularStructure-Activity RelationshipChondroitin SulfatesGlycosaminoglycansHyaluronic AcidImmobilized ProteinsKDR protein, humanVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-2VEGFA protein, human

Identifiers

PMID31792253
PMCPMC6889296
OpenAlexW2991046214

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.